Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2026-03-12 @ 12:01 PM
Study NCT ID:
NCT02625168
Status:
COMPLETED
Last Update Posted:
2015-12-09
First Post:
2015-12-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Afatinib vs Erlotinib as 2nd TKI After Failure to 1st TKI and Chemotherapy for Metastatic NSCLC
Sponsor:
Organization: